Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-03

FDA Approved: RUFINAMIDE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for Rufinamide submitted by Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rufinamide (Rufinamide)

Snippet

SUPPL AP for RUFINAMIDE (RUFINAMIDE)